secwatch.observer — SEC 8-K summary
======================================

Issuer:     ICU MEDICAL INC/DE (ICUI)
CIK:        0000883984
Form:       8-K
Filed at:   2026-02-19T23:59:59+00:00
Accession:  0000883984-26-000007
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ICU Medical Q4: revenue $540.7M (-14% YoY), GAAP loss $(0.64)/share, adj EPS $1.91
--------------------------------------------------------------------------------

- Revenue $540.7M vs $629.8M in Q4 2024, down 14.1% YoY.
- GAAP net loss $(15.7)M, or $(0.64) per diluted share, improving from $(23.8)M loss in Q4 2024.
- Adjusted diluted EPS $1.91, down from $2.11; Adjusted EBITDA $98.2M vs $105.5M.
- GAAP gross margin improved to 38% from 36%.
- Fiscal 2026 guidance provided but numerical details not included in filing excerpt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883984/000088398426000007/0000883984-26-000007-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883984/000088398426000007/icui-20260219.htm
  HTML page:      https://secwatch.observer/filing/0000883984-26-000007

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer